Associate Scientist II, Analytical Development, Raw Materials (contract) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Vaxcyte · 8 hours ago

Associate Scientist II, Analytical Development, Raw Materials (contract)

positionSan Carlos, CA
timeContract
remoteOnsite
seniorityEntry, Mid Level
money$51/hr - $56/hr
date2+ years exp

Vaxcyte is a clinical-stage vaccine innovation company focused on developing high-fidelity vaccines to combat bacterial diseases. They are seeking an energetic individual to join their analytical development team, responsible for method development, sample testing, data analysis, and authoring protocols and reports.

BiopharmaBiotechnologyHealth Care
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Assist in analytical method development of new assays
Perform analytical testing, data analysis and present in team meetings
Maintain thorough and accurate records of laboratory work
Support daily lab operations, sample inventory and sample shipment
Author analytical documents including but not limited to test method, protocols, and reports

Qualification

Analytical method developmentChemical assaysBiological assaysHPLCPCR/qPCRELISALC-MSRecord keepingAttention to detailInterpersonal skillsEffective communication

Required

BS in Chemistry with 2+ years of relevant industry experience, or MS with 1+ years of experience
Experience in chemical and biological assays such as colorimetric/ fluorometric microplate assays, PCR/qPCR, HPLC, CE, UV-Vis, ELISA and LC-MS
Understanding of basic principles of analytical method development/ validation/ qualification concepts
Attention to detail and excellent skills in record keeping/documentation
Strong interpersonal skills and ability to communicate effectively both verbally and in written formats
This position is a lab-based role and requires onsite presence

Preferred

Analytical Chemistry preferred
Organic / Biochemistry considered

Company

Vaxcyte

twittertwitter
company-logo
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
dateFounded in 2013
location
San Carlos, California, USA
people-size201-500 employees
web-link
http://www.vaxcyte.com

H1B Sponsorship

Vaxcyte has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (7)
2023 (5)
2022 (7)
2021 (2)

Funding

Current Stage
Public Company
Total Funding
$3.85B
Key Investors
CARB-XTPG GrowthAbingworth
2024-09-04Post Ipo Equity· $1.5B
2024-01-30Post Ipo Equity· $862.5M
2023-04-19Post Ipo Equity· $500M

Leadership Team

leader-logo
Andrew Guggenhime
President & Chief Financial Officer
linkedin
leader-logo
Jeff Fairman
Founder and Vice President, Research
linkedin

Recent News

Investing
Wall Street's top stock picks for 2026: Mizuho’s under-the-radar name that could more than triple in value
2025-12-20
thefly.com
Vaxcyte announces first participants dosed in OPUS Phase 3 trial of VAX-31
2025-12-09
MarketScreener
Vaxcyte Doses First Participants in the OPUS Phase 3, Noninferiority Trial Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults
2025-12-08
Company data provided by crunchbase